CMS has again suspended enrollment for two Medicare Advantage prescription drug plans offered by Boston-based EternalHealth, the second time in less than two years that the insurer has faced sanctions.
The agency said Aug. 27 the enrollment freeze on the two plans is based on its determination that EternalHealth’s conduct “poses a serious threat to enrollee health and safety.”
The sanction follows an Aug. 12 order from the Massachusetts Division of Insurance placing EternalHealth under administrative supervision and requiring the insurer to suspend new business until it meets certain financial requirements set by the state.
Because EternalHealth cannot accept new enrollments under its state license, CMS said it is out of compliance with its federal contract requirements. The enrollment freeze will remain in place until Massachusetts regulators confirm EternalHealth is back in good standing and the state order has been removed.
EternalHealth faced similar sanctions in 2025 after Massachusetts barred the insurer from marketing its products over financial solvency concerns. CMS lifted that sanction in September after the state withdrew its restrictions, but warned at the time that future noncompliance could result in additional sanctions, civil money penalties or contract termination.
EternalHealth has about 10,000 members across Massachusetts and Arizona, according to CMS data. Becker’s has reached out to the company for comment.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
